Dr Andrew Lozano Jr, MD | |
2505 Samaritan Dr, #606, San Jose, CA 95124 | |
(408) 358-3774 | |
(408) 358-7202 |
Full Name | Dr Andrew Lozano Jr |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 2505 Samaritan Dr, San Jose, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831234095 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | G38738 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Andrew Lozano Jr, MD 2505 Samaritan Dr, #606, San Jose, CA 95124 Ph: (408) 358-3774 | Dr Andrew Lozano Jr, MD 2505 Samaritan Dr, #606, San Jose, CA 95124 Ph: (408) 358-3774 |
News Archive
Shiseido Co., Ltd. has long focused its research on skin immunity as an important means of maintaining skin's health, and protecting it from external and internal stressors that can lead to dermatologic problems.
When an adolescent female patient comes to Nationwide Children's Hospital's Sports Medicine clinic, not only are these young women treated for their sports-related injury, but their sports medicine physician will also ask if they've missed any periods, because of a growing concern among female athletes.
UK scientists may have found a way to destroy HIV's last refuge. A study by Oxford University has confirmed that a treatment developed by a British company can remove the virus in its chosen hiding place, in laboratory conditions, offering hope of a viable treatment.
Par Pharmaceutical Companies, Inc. today announced that it has entered into a definitive agreement to acquire JHP Group Holdings, the parent company of JHP Pharmaceuticals, a leading specialty pharmaceutical company that develops, manufactures and markets branded and generic sterile injectable products.
NOXXON Pharma AG announced today that it has permission to commence a multiple ascending dose study of its Monocyte Chemoattractant Protein-1 (MCP-1) targeting anti-inflammatory SpiegelmerĀ®, NOX-E36. NOXXON plans to develop NOX-E36 for the treatment of diabetic nephropathy and other diabetes related complications.
› Verified 6 days ago
Alan B Goldsobel, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Moorpark Ave, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-551-2394 | |
Carrie A Kaufmann, CPNP Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Moorpark Avenue, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-553-0750 | |
James D Wolfe, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Moorpark Ave, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-553-0750 | |
Anlin Xu, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 130 Bellerose Dr, San Jose, CA 95128 Phone: 408-286-1707 Fax: 408-286-1744 | |
Robert T Torrano, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4050 Moorpark Avenue, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-553-0750 | |
Kristi M Annecone, FNP Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4050 Moorpark Avenue, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-553-0750 | |
Thomas Richard Santora, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4050 Moorpark Avenue, San Jose, CA 95117 Phone: 408-243-2700 Fax: 408-553-0750 |